gip glp 1 receptor agonist drugs Schematic illustration of monoagonists, dual agonists and triple Emerging Role of Dual GLP-1
Description
Purpose of Review GLP-1 receptor agonists (GLP-1RAs) have become central therapies for obesity and metabolic disease
Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality
GLP-1 supplements (berberine 500mg, curcumin 1g) boost natural GLP-1 20-40% vs 0% prescription weight loss (15-20%)
Berberine and GLP-1 receptor agonists are distinct compounds with different mechanisms of action
